RO5545965
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for RO5545965, covering 2016-11-02 to 2017-06-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics [Phase 1]